Topics

Our 4Q19 drug pipeline Data Page shows a host of innovative drug modality approvals, including the 1st single-chain nanobody in the US, an antibiotic against Gram-negative bacteria, 2 drugs for sickle cell anemia and a triple-drug combo for cystic fibrosi

13:29 EST 11 Feb 2020 | Nature Publishing

Our 4Q19 drug pipeline Data Page shows a host of innovative drug modality approvals, including the 1st single-chain nanobody in the US, an antibiotic against Gram-negative bacteria, 2 drugs for sickle cell anemia and a triple-drug combo for cystic fibrosis https://rdcu.be/b1xGO 

Original Article: Our 4Q19 drug pipeline Data Page shows a host of innovative drug modality approvals, including the 1st single-chain nanobody in the US, an antibiotic against Gram-negative bacteria, 2 drugs for sickle cell anemia and a triple-drug combo for cystic fibrosi

NEXT ARTICLE

More From BioPortfolio on "Our 4Q19 drug pipeline Data Page shows a host of innovative drug modality approvals, including the 1st single-chain nanobody in the US, an antibiotic against Gram-negative bacteria, 2 drugs for sickle cell anemia and a triple-drug combo for cystic fibrosi"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...